Johnson &amp; Johnson $JNJ +4.5% on Q1 sales +3.3% &amp; adj. earnings +8.7%. Consumer sales +9.2% &amp; Pharmaceutical +8.7% on consumer stockpiling. Medical Devices -8.2% on postponement of elective surgeries. JNJ hopes to produce 1 bln Covid-19 vaccinations by early '21. (Bloomberg)

#MBA https://t.co/OLAuUa4uZA